Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MediClin financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€2.2
2024-10-29
Market Capitalization
€111 M
2024-10-29
Revenue
€730.1 M
FY, 2023
CreditSafe Score
?
Score changed on Apr 29, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 645.1M | 673.1M | 659.9M | 673.1M | 704.7M | 730.1M |
| Cost of goods sold | 119.4M | 121.0M | 112.7M | 122.1M | 132.8M | 137.4M |
| Gross profit | 535.6M | 565.5M | 558.3M | 564.8M | 589.4M | 627.5M |
| Gross profit margin, % | 84.0% | |||||
| Operating expense total | 498.2M | 471.9M | 480.8M | 479.7M | 498.6M | 528.7M |
| Depreciation and amortization | 22.3M | 71.2M | 77.3M | 73.7M | 71.4M | 86.0M |
| EBITDA | 37.3M | 93.6M | 77.5M | 85.2M | 90.9M | 98.7M |
| EBITDA margin, % | 13.9% | |||||
| EBIT | 15.1M | 22.4M | 150.0K | 11.6M | 19.5M | 12.7M |
| EBIT margin, % | 3.3% | |||||
| Interest income | 234.0K | 85.0K | 51.0K | 48.0K | 881.0K | 2.5M |
| Interest expense | 3.5M | 10.9M | 10.3M | 9.3M | 10.6M | 23.9M |
| Pre tax profit | 11.9M | 11.6M | (10.1M) | 2.4M | 9.8M | (8.7M) |
| Income tax expense | 4.1M | 1.9M | (1.1M) | 961.0K | 58.0K | 2.0M |
| Net Income | 7.8M | 9.7M | (9.0M) | 1.5M | 9.7M | (10.7M) |